NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,000
-33.3%
80
-7.0%
0.00%
Q2 2021$3,000
+200.0%
86
+7.5%
0.00%
Q1 2020$1,000
-66.7%
80
-18.4%
0.00%
Q2 2019$3,000
+50.0%
98
+117.8%
0.00%
Q1 2019$2,000
-84.6%
45
-91.3%
0.00%
Q4 2016$13,000
+8.3%
518
-9.0%
0.00%
Q2 2016$12,000
+20.0%
569
-16.1%
0.00%
Q1 2016$10,0006780.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders